BioBrace® Reinforced Implant
Mesh, Surgical, Absorbable, Orthopaedics, Reinforcement Of Tendon. 510(k) K241906, from Conmed Corporation (Utica, NY). Product code OWW, class 2.
As of Nov 19, 2026, K241906 is an FDA 510(k) held by Conmed Corporation, substantially equivalent on Jul 29, 2024 after 28 days, with no recalls tied to it in FDA's recall database.
- Review time: 28 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The BioBrace® Implant is intended for use in general surgical procedures for reinforcement of soft tissue where weakness exists. The BioBrace® Implant is also intended for reinforcement of soft tissues that are repaired by suture or suture anchors, during tendon repair surgery including reinforcement of rotator cuff, patellar, Achilles, biceps, or quadriceps tendons.
- The BioBrace ImplantK203267 · Biorez, Inc. · Apr 30, 2021
- BioBrace ® RC Delivery SystemK250395 · Conmed Corporation · Apr 7, 2025
- BioBrace®K242187 · Conmed Corporation · Nov 27, 2024
- BioChargeK263682 · Nanofiber Solutions, LLC · Nov 5, 2026
- DynaviscK262343 · Fziomed, Inc. · Oct 28, 2026
- VersaCoat Tendon Protector (VTP-44G2); VersaCoat Tendon Protector (VTP-12G1)K251655 · Alafair Biosciences · Jul 18, 2025
- RotiumK250021 · Nanofiber Solutions, LLC · Feb 27, 2025
- BioBrace®K242187 · Conmed Corporation · Nov 27, 2024
- VersaWrapK240817 · Alafair Biosciences, Inc. · Jun 14, 2024
- SpinMedix Absorbable Fibrous MembraneK222220 · Celestray Biotech Company, LLC., · Jul 6, 2023
- FlexBand; FlexPatch; FlexBand PlusK230316 · International Life Sciences · May 26, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jul 1, 2024
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.3300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files